Candel Therapeutics Competitors and Similar CompaniesClear all

Candel Therapeutics's competitors and similar companies include ESSA Pharma, Signpath Pharma and Trethera.

	Candel Therapeutics Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies.	ESSA Pharma ESSA Pharma is a pharmaceutical company focused on developing therapies for the treatment of prostate cancer.	Signpath Pharma SignPath Pharma is a biotechnology company that develops products to treat cancer and mitigate drug-induced cardiac arrhythmia.	Trethera Trethera is a preclinical-stage biopharmaceutical company developing cancer treatments.
Founding Date	Founding Date 1999	Founding Date 2009	Founding Date 2006	Founding Date 2013
Type	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Manufacturing & Industrial drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Needham, US HQ	Locations Vancouver, CA HQ Houston, US South San Francisco, US	Locations Sandy, US HQ	Locations Los Angeles, US HQ
Employees	Employees 50	Employees 50	Employees 10	Employees 6
Valuation ($)	Valuation ($) 222.3 m	Valuation ($) 257.8 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Net income	Net income ($37.9m) (FY, 2023)	Net income ($26.6m) (FY, 2023)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 64.6m	Total funding raised $ 74.1m	Total funding raised $ 5.3m	Total funding raised $ 7.4m